Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.

@article{Rutten2010BetablockersMR,
  title={Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.},
  author={Frans Hendrik Rutten and Nicolaas P. A. Zuithoff and Eelko Hak and Diederick E. Grobbee and Arno Wilhelmus Hoes},
  journal={Archives of internal medicine},
  year={2010},
  volume={170 10},
  pages={880-7}
}
BACKGROUND Physicians avoid the use of beta-blockers in patients with chronic obstructive pulmonary disease (COPD) and concurrent cardiovascular disease because of concerns about adverse pulmonary effects. We assessed the long-term effect of beta-blocker use on survival and exacerbations in patients with COPD. METHODS An observational cohort study using data from the electronic medical records of 23 general practices in the Netherlands. The data included standardized information about daily… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 108 extracted citations

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease • 2015
View 11 Excerpts
Highly Influenced

β-blockade: benefits beyond blood pressure reduction?

Journal of clinical hypertension • 2012
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 33 references

American College of Cardiology Foundation; American Heart Association

SA Hunt, WT Abraham, MH Chin
J Am Coll Cardiol • 2009

update : endorsed by the National Heart , Lung , and Blood Institute

SA Hunt, WT Abraham, MH Chin
Circulation • 2009

Similar Papers

Loading similar papers…